|
|
| | 3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone Basic information |
| Product Name: | 3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone | | Synonyms: | (3beta,5alpha,7beta,15beta,20xi)-3,7,15,20-Tetrahydroxy-4,4,14-trimethyl-11-oxo-chol-8-en-24-oic acid gamma-lactone;3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone;3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→3beta,7beta,15beta-trihydroxy-11-oxo-lanosta-8-en-24->20 lactone;Chol-8-en-24-oic acid, 3,7,15,20-tetrahydroxy-4,4,14-trimethyl-11-oxo-, γ-lactone, (3β,5α,7β,15β,20ξ)-;3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone | | CAS: | 1694587-15-9 | | MF: | C27H40O6 | | MW: | 460.6 | | EINECS: | | | Product Categories: | | | Mol File: | 1694587-15-9.mol |  |
| | 3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone Chemical Properties |
| | 3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone Usage And Synthesis |
| Uses | 3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone is a natural compound that could be isolated from G. lucidum with antimycobacterial activity. | | References | [1] By Li, et al. Pharmaceutical compounds separated and extracted from Ganoderma lucidum and method and uses thereof. Patent CN 104478983 A. |
| | 3β,7β,15β-trihydroxy-11-oxo-lanosta-8-en-24→20 lactone Preparation Products And Raw materials |
|